The Molecular Biology Society of Japan

[3LBA-090] Targeted cancer therapy via activation of p53 pathway preferentially in cancer cells

〇Kohichi Kawahara1, Tatsuhiko Furukawa1 (1.Dept. of Mol. Oncol., Grad. Sch. of Med. and Dent. Sci., Kagoshima Univ.)

TP53, Molecular Target Therapy for cancer, Nucleolar stress response, Side effect, Chemical Screening

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password